StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a report released on Friday morning. The firm issued a hold rating on the software maker's stock.
Veradigm Price Performance
Shares of Veradigm stock traded down $0.14 during trading hours on Friday, hitting $9.26. The company's stock had a trading volume of 1,155,440 shares, compared to its average volume of 1,650,186. The business has a 50 day moving average price of $9.52 and a two-hundred day moving average price of $9.14. Veradigm has a 12-month low of $5.01 and a 12-month high of $13.62.
Institutional Investors Weigh In On Veradigm
Large investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker's stock valued at $149,754,000 after buying an additional 95,291 shares during the last quarter. Tyro Capital Management LLC bought a new position in shares of Veradigm during the first quarter valued at approximately $9,055,000. Finally, Innealta Capital LLC bought a new position in shares of Veradigm during the second quarter valued at approximately $38,000.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
